v3.26.1
Financial Instruments (Tables)
12 Months Ended
Jun. 28, 2026
Fair Value Disclosures [Abstract]  
Schedule of Cash, Cash Equivalents, Investments, and Other Assets Measured at Fair Value on Recurring Basis
The financial instruments reported within Cash and cash equivalents in the Company’s Consolidated Balance Sheets as of June 28, 2026, and June 29, 2025 consisted of the following:
June 28,
2026
June 29,
2025
(in thousands)
Money market funds (fair value measured on a recurring basis, level 1)$2,015,275 $3,151,084 
Cash2,071,271 1,662,236 
Time deposits1,492,625 1,577,339 
Total$5,579,171 $6,390,659